Ovariancancer remains one of the most difficult cancers to treat. Recent clinical research continues to show promise for women with advanced stages of the disease. See why Dr. Scot Ebbinghaus remains optimistic. httpmerck.us2Wzgg0k ASCO19pic.twit

#Ovariancancer remains one of the most difficult cancers to treat. Recent clinical research continues to show promise for women with advanced stages of the disease. See why Dr. Scot Ebbinghaus remains optimistic. http://merck.us/2Wzgg0k  #ASCO19pic.twit

13:00 EDT 3 Jun 2019 | Merck & Co., Inc.

#Ovariancancer remains one of the most difficult cancers to treat. Recent clinical research continues to show promise for women with advanced stages of the disease. See why Dr. Scot Ebbinghaus remains optimistic. http://merck.us/2Wzgg0k  #ASCO19 pic.twitter.com/Qa4BPCtCLK

More From BioPortfolio on "#Ovariancancer remains one of the most difficult cancers to treat. Recent clinical research continues to show promise for women with advanced stages of the disease. See why Dr. Scot Ebbinghaus remains optimistic. http://merck.us/2Wzgg0k  #ASCO19pic.twit"